Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) neutralization counteracts T cell immune evasion in breast cancer.
Cristina TravelliGiorgia ColomboMartina AliottaFrancesca FagianiNatalia FavaRita De SanctisAmbra A GrollaJoe G N GarciaNausicaa ClementePaola PortararoMassimo CostanzaFabrizio CondorelliMario Paolo ColomboSabina SangalettiArmando A GenazzaniPublished in: Journal for immunotherapy of cancer (2023)
These studies indicate for the first time eNAMPT as a novel immunotherapeutic target for triple negative breast cancer.
Keyphrases